ES8600276A1 - Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles - Google Patents

Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles

Info

Publication number
ES8600276A1
ES8600276A1 ES526120A ES526120A ES8600276A1 ES 8600276 A1 ES8600276 A1 ES 8600276A1 ES 526120 A ES526120 A ES 526120A ES 526120 A ES526120 A ES 526120A ES 8600276 A1 ES8600276 A1 ES 8600276A1
Authority
ES
Spain
Prior art keywords
phenylene
thio
alkylene
oxy
carbon atoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526120A
Other languages
English (en)
Other versions
ES526120A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES526120A0 publication Critical patent/ES526120A0/es
Publication of ES8600276A1 publication Critical patent/ES8600276A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR NUEVOS N-SUSTITUIDO-2-(1-IMIDAZOLIL)-INDOLES.COMPRENDE: CONDENSAR UN COMPUESTO DE FORMULA (II), CON UN DERIVADO FUNCIONAL REACTIVO DE UN COMPUESTO DE FORMULA (III), PARA OBTENER N-SUSTITUIDO-2 (1-IMIDAZOLIL)-INDOLES, DE FORMULA (I), EN DONDE R1 ES HIDROGENO O ALQUILO INFERIOR, IM ES 1-IMIDAZOLILO INSUSTITUIDO O SUSTITUIDO POR ALQUILO INFERIOR, CARBOXI, ALCOXI (INFERIOR) CARBONILO O CARBOMOILO, R2 Y R3 SON HIDROGENO, ALQUILO INFERIOR, HALOGENO, TRIFLUORMETILO, HIDROXI U OTROS, R2 Y R3 JUNTOS, CUANDO ESTAN UNIDOS A CARBONES ADYACENTES, SON ALQUILENO (INFERIOR) DIOXI, A ES ALQUILENO DE C 1 A 12, ALQUINILENO DE C 2 A 12, ALQUINILENO DE C 2 A 12, U OTROS, B ES CARBOXI, ALCOXI (INFERIOR) CARBOMOILO, CIANO, HIDROXIMETILO, HIDROXI-CARBOMOILO, 5-TETRAZOLILO O FORMILO.SE UTILIZAN PARA EL TRATAMIENTO DE ENFERMEDADES SENSIBLES A LA INHIBICION DE SINTETASA DE TROMBOXANO EN MAMIFEROS.
ES526120A 1982-09-30 1983-09-29 Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles Expired ES8600276A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/430,644 US4436746A (en) 1982-09-30 1982-09-30 Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles

Publications (2)

Publication Number Publication Date
ES526120A0 ES526120A0 (es) 1985-10-01
ES8600276A1 true ES8600276A1 (es) 1985-10-01

Family

ID=23708431

Family Applications (2)

Application Number Title Priority Date Filing Date
ES526120A Expired ES8600276A1 (es) 1982-09-30 1983-09-29 Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles
ES543691A Expired ES8608514A1 (es) 1982-09-30 1985-05-30 Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543691A Expired ES8608514A1 (es) 1982-09-30 1985-05-30 Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles

Country Status (10)

Country Link
US (1) US4436746A (es)
EP (1) EP0107618B1 (es)
JP (1) JPS5982385A (es)
AU (1) AU1971683A (es)
CA (1) CA1207327A (es)
DE (1) DE3364528D1 (es)
DK (1) DK448783A (es)
ES (2) ES8600276A1 (es)
FI (1) FI833489A (es)
GR (1) GR81266B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539410A (en) * 1982-09-30 1985-09-03 Ciba-Geigy Corporation N-Substituted-2-(1-imidazolyl)indoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
GB8707051D0 (en) * 1986-04-15 1987-04-29 Ici America Inc Heterocyclic carboxamides
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
NZ223660A (en) * 1987-03-05 1990-11-27 Liposome Co Inc Low toxicity drug-lipid complexes; methods of making them; and method of determining their toxicity
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
GB9022858D0 (en) * 1990-10-20 1990-12-05 Reckitt & Colmann Prod Ltd Derivatives of indoles
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370063A (en) 1964-10-05 1968-02-20 Mcneilab Inc Substituted dimethoxy indoles and method of making the same
US4059583A (en) 1975-11-13 1977-11-22 Mcneil Laboratories, Incorporated Substituted indoles
US4140858A (en) 1977-12-19 1979-02-20 Warner-Lambert Company 3-(1H-imidazol-1-ylmethyl)-2-(disubstitutedaminomethyl)indoles and a method for their production
DE2960547D1 (en) 1978-02-24 1981-11-05 Pfizer Ltd 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
DK151884C (da) 1979-03-07 1988-06-13 Pfizer Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
US4436911A (en) * 1981-05-12 1984-03-13 William H. Rorer, Inc. Heterocyclic amidinoureas

Also Published As

Publication number Publication date
JPS5982385A (ja) 1984-05-12
EP0107618B1 (en) 1986-07-16
ES543691A0 (es) 1986-06-16
US4436746A (en) 1984-03-13
FI833489A0 (fi) 1983-09-28
EP0107618A1 (en) 1984-05-02
CA1207327A (en) 1986-07-08
AU1971683A (en) 1984-04-05
DK448783A (da) 1984-03-31
DE3364528D1 (de) 1986-08-21
GR81266B (es) 1984-12-11
ES526120A0 (es) 1985-10-01
FI833489A (fi) 1984-03-31
ES8608514A1 (es) 1986-06-16
DK448783D0 (da) 1983-09-29

Similar Documents

Publication Publication Date Title
ES8600276A1 (es) Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles
ES8704461A1 (es) Procedimiento para la produccion de derivados diarilicos de compuestos antiinflamatorios antialergicos.
DE69901969T2 (de) Benzimidazole Derivate als Cyclooxygenase-2 Inhibitoren
ES8608508A1 (es) Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos
IE833008L (en) IMIDAZO £1,5-a| PYRIDINE DERIVATIVES
IE881788L (en) Cycloalkylamides of (8-beta)-1-alkyl-6-(substituted)¹ergolines
ES8802222A1 (es) Un procedimiento para preparar derivados de vinilisoquinolina
ES8702906A1 (es) Procedimiento para la preparacion de 2-(piridil e imidazolil)-indoles
ZA875355B (en) Fungicides
AU3905189A (en) 1-halo-1-azolylpropenes and -methyloxiranes and fungicides containing these compounds
GB8619433D0 (en) Pharmaceutical compounds
GB9207961D0 (en) Heterocyclic derivatives
ES8203370A1 (es) Procedimiento de preparar 6-hidrazonopirido(2,1-b)quinazo- lin-11-onas y similares
GR3015713T3 (en) Pyridoindole derivatives and processes for preparation thereof.
DE3569380D1 (en) Pyridylphenylpyridazinone inotropic agents
ES8506712A1 (es) Un procedimiento para la preparacion de derivados de fenilimidazol.
ES8506722A1 (es) Un procedimiento para la preparacion de derivados de -lactama
ES8601969A1 (es) Un procedimiento para preparar derivados de piridona
ES8604392A1 (es) Un procedimiento para preparar derivados de pirazinona.
GB2196963B (en) Histamine h1 antagonists
MX9802103A (es) Nuevos imidazoles inhibidores de la lipoxigenasa, composiciones que los contienen y uso de los mismos.